Compounded semaglutide, which is made specifically for each patient, is not FDA approved and has not undergone the same testing as Ozempic
One risk of taking GLP-1s for weight loss is the unintentional loss of muscle mass (aka lean mass) as you slim down
While anyone can develop kidney stones, the following will increase your risk: Dehydration due to dry climate or from intense exercise or you simply don't drink enough water Obesity Metabolic conditions such as cystinuria, oxaluria or gout Use of certain drugs such as protease inhibitors, antibiotics, some diuretics and calcium-based antacids Diseases or surgery of the digestive tract including inflammatory bowel disease and gastric bypass surgery A diet rich in salt, protein, refined sugars and soft drinks You have had kidney stones in the past Family history of kidney stones Structural abnormalities in the kidney such as ureteropelvic junction obstruction, urinary diversion surgery, horseshoe kidney You have polycystic kidney disease or another cystic kidney disease Your urine contains high levels of cystine, oxalate, uric acid or calcium If kidney stones are suspected, your health care provider will order tests to determine if you have kidney stones and to develop a treatment plan
So, if there is a test or measurement or observation that is appropriate if the patient was being seen in-office, it is likely that will need to be adequately replicated when using an audio/video telehealth system
How do Ozempic and Wegovy lead to weight loss
